MEDICINE DETAILS
Entresto
Active ingredient: Sacubitril Valsartan
Neutral reference profile for an independent medicine-access consultancy enquiry about Entresto (Sacubitril Valsartan). No medicine is offered for sale.
LEGACY INFORMATION PAGE
This record is retained for information continuity.
This medicine is not currently in the live enquiry directory. You can review the identity and catalogue details below, but an enquiry cannot be created from this page.
Return to the live directory→Retaining this page does not imply stock, access or a medicine sale.
ABOUT THIS MEDICINE
What is Entresto used for?
Entresto (sacubitril/valsartan) is a neprilysin inhibitor and angiotensin II receptor blocker combination used to treat:
- Adults with long-lasting (chronic) heart failure to help reduce the risk of death and hospitalization.
- Pediatric patients aged one year and older with symptomatic heart failure who have systemic left ventricular systolic dysfunction.
The medicine works better in patients whose heart cannot pump a normal amount of blood to the body.
It is available in tablet form, each containing 24 mg/26 mg, 49 mg/51 mg, or 97 mg/103 mg sacubitril/valsartan.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Entresto identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
6 mg/6 mg · 60 capsules Catalogue organisation: NOVARTIS Pharma GmbH
-
15 mg/16 mg · 60 capsules Catalogue organisation: NOVARTIS Pharma GmbH
-
24 mg/26 mg · 20 tablets Catalogue organisation: NOVARTIS Pharma GmbH
-
24 mg/26 mg · 56 tablets Catalogue organisation: NOVARTIS Pharma GmbH
-
24 mg/26 mg · 196 tablets Catalogue organisation: NOVARTIS Pharma GmbH
-
49 mg/51 mg · 20 tablets Catalogue organisation: NOVARTIS Pharma GmbH
-
49 mg/51 mg · 56 tablets Catalogue organisation: NOVARTIS Pharma GmbH
-
49 mg/51 mg · 196 tablets Catalogue organisation: NOVARTIS Pharma GmbH
-
97 mg/103 mg · 20 tablets Catalogue organisation: NOVARTIS Pharma GmbH
-
97 mg/103 mg · 56 tablets Catalogue organisation: NOVARTIS Pharma GmbH
-
97 mg/103 mg · 196 tablets Catalogue organisation: NOVARTIS Pharma GmbH
OFFICIAL SOURCES
Check the Entresto record at an official source.
Search for “Entresto” or “Sacubitril Valsartan”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Entresto.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Entresto
01What is Entresto?＋
This directory record associates the brand name Entresto with the active ingredient Sacubitril Valsartan. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Entresto strengths and packs are recorded?＋
The catalogue currently shows: 6 mg/6 mg · 60 capsules; 15 mg/16 mg · 60 capsules; 24 mg/26 mg · 20 tablets; 24 mg/26 mg · 56 tablets. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Entresto?＋
Catalogue records currently name: NOVARTIS Pharma GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Entresto?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Entresto, payment request, stock guarantee or binding offer.
06Can I buy Entresto from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.